Syndax Pharmaceuticals Inc·4

May 19, 4:01 PM ET

Katkin Keith 4

4 · Syndax Pharmaceuticals Inc · Filed May 19, 2025

Insider Transaction Report

Form 4
Period: 2025-05-19
Katkin Keith
Director
Transactions
  • Purchase

    Common Stock

    2025-05-19$9.11/sh+10,000$91,120100,000 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4